Bluejay Diagnostics, Inc. (BJDX) stock
BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.61+0.00 (+0.19%)
Close on Nov 13, 2026Market cap $2.92MP/E –Yield –
Bluejay Diagnostics ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Bluejay Diagnostics's ebitda for the twelve months ending Dec 31, 2022 was -$9.16M. For fiscal 2022 it was -$9.16M.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -$9.16M | – |
| FY2021 | Dec 31, 2021 | -$3.08M | – |
| FY2020 | Dec 31, 2020 | -$1.04M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -$2.42M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.77M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.94M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.03M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.33M | – |
| Q3 FY2021 | Sep 30, 2021 | -$919.85K | – |
| Q2 FY2021 | Jun 30, 2021 | -$638.53K | – |
| Q1 FY2021 | Mar 31, 2021 | -$192.37K | – |
| Q4 FY2020 | Dec 31, 2020 | -$535.88K | – |
See a number that looks wrong?